| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.048 | 0.09 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.051 | 0.09 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |